NEW YORK (GenomeWeb) – Biocept on Tuesday provided details regarding its previously announced plans to distribute subscription rights to certain shareholders of its common stock and warrants to purchase 25,000 securities units for a total of $25 million.

Biocept originally announced the distribution of the subscription rights in May. The subscription rights are being distributed to holders of common stock and warrants that Biocept issued Feb. 13, 2015; May 4, 2016; Oct. 19 2016; March 31, 2017; Aug. 9, 2017; and Jan. 30, 2018.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.